Literature DB >> 207481

99MTc-metyhlene diphosphonate concentration in soft tissue malignant fibrous histiocytoma.

L Rosenthall.   

Abstract

Four cases of non-calcifying soft tissue malignant fibrous histiocytoma are presented which showed concentration of 99mTc-methylene diphosphonate. Angiography was performed in one of the patients and it featured hypervascularity, tumor staining and early draining veins indicative of arteriovenous shunting. As with other extraskeletal non-calcifying entities which exhibit enhanced uptake of 99mTc-phosphate complex, the mechanism of concentration is largely conjectural. Malignant fibrous histiocytoma can be added to the expanding list of conditions which may portray in avidity for 99mTc-phosphate complex.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207481     DOI: 10.1097/00003072-197802000-00007

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Better visualization of a lung tumour with 99mTc-DPD than with 99mTc-glucoheptonate or 67Ga-citrate.

Authors:  M Vorne; T Lantto; K Sahlström; S Sakki; S Vähätalo
Journal:  Eur J Nucl Med       Date:  1986

2.  Role of technetium-99m pertechnetate scintigraphy in the management of extra-abdominal fibromatosis.

Authors:  S Terui; T Terauchi; H Abe; Y Muramatsu; H Fukuma; Y Beppu; R Yokoyama
Journal:  Skeletal Radiol       Date:  1995-07       Impact factor: 2.199

3.  Transient splenic uptake of 99mTc-MDP associated with haemolysis.

Authors:  C C Alevizaki; E Georgiou; E Nikiforakis; C Proukakis
Journal:  Eur J Nucl Med       Date:  1982

4.  Case report 163: Hemangiopericytoma of the soft tissues in the area of the left scapula.

Authors:  J P McGahan; S K Hansen; P E Palmer
Journal:  Skeletal Radiol       Date:  1981       Impact factor: 2.199

5.  Tc-99m-methylene diphosphonate (Tc-99 MDP) and Ga-67 concentration in soft tissue malignant fibrous histiocytoma (MFH): case report.

Authors:  T Kida; K Hoshi; R Hoshino; Y Fujita; S Munakata; M Yanagisawa
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.